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Human serum albumin alters 
specific genes that can play a 
role in survival and persistence in 
Acinetobacter baumannii
Brettni Quinn1, Nyah Rodman1, Eugenio Jara2, Jennifer S. Fernandez1, Jasmine Martinez1, 
German M. Traglia3, Sabrina Montaña4, Virginia Cantera8, Kori Place1, Robert A. Bonomo5,6,7, 
Andres Iriarte8 & María Soledad Ramírez1
In the past few decades Acinetobacter baumannii has emerged as a notorious nosocomial pathogen 
because of its ability to acquire genetic material and persist in extreme environments. Recently, 
human serum albumin (HSA) was shown to significantly increase natural transformation frequency 
in A. baumannii. This observation led us to perform transcriptomic analysis of strain A118 under HSA 
induction to identify genes that are altered by HSA. Our results revealed the statistically significant 
differential expression of 296 protein-coding genes, including those associated with motility, biofilm 
formation, metabolism, efflux pumps, capsule synthesis, and transcriptional regulation. Phenotypic 
analysis of these traits showed an increase in surface-associated motility, a decrease in biofilm 
formation, reduced activity of a citric acid cycle associated enzyme, and increased survival associated 
with zinc availability. Furthermore, the expression of genes known to play a role in pathogenicity and 
antibiotic resistance were altered. These genes included those associated with RND-type efflux pumps, 
the type VI secretion system, iron acquisition/metabolism, and ß-lactam resistance. Together, these 
results illustrate how human products, in particular HSA, may play a significant role in both survival and 
persistence of A. baumannii.
A. baumannii is a pathogen that manifests a multi-drug-resistant (MDR) phenotype and infects patients in the 
critical care unit. As a result, outcomes are poor and the cost of care escalates1–3. Last year, the World Health 
Organization published a list of 12 antibiotic-resistant “priority pathogens” in which A. baumannii was listed as 
the first priority one pathogen for antibiotic research and development4. Some intrinsic features, such as the bac-
terium’s ability to persist in the clinical setting even under desiccation, nutrient starvation, and high concentra-
tions of antimicrobials have allowed A. baumannii to become a major hospital-acquired pathogens5. In addition, 
extreme genome plasticity combined with its ability to acquire resistance determinants, play a key role in the evo-
lution of A. baumannii’s phenotype. Comparative genomic studies have shown high variability in Acinetobacter’s 
genome organization, as well as the presence of foreign DNA in their genomes, suggesting exogenous acquisition 
of genetic traits6–9.
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Due to the shrinking number of effective antimicrobials to treat A. baumannii infections, it is critical to under-
stand the mechanisms of A. baumannii pathogenesis. Known virulence factors in A. baumannii, such as OmpA, 
phospholipase D, lipopolysaccharides, and production of the K1 capsule, promote colonization and can damage 
the host10. These factors can contribute to the pathogen’s overall survival against host immune effectors, however, 
these are not the only strategies the microbe may use to promote persistence. The persistence state is an evolution-
arily adaptive strategy indicated by a change in metabolic profile, latent growth patterns, and has been associated 
with expression of toxin/antitoxin systems11,12. Persistence phenotypes are environmentally modulated, therefore, 
it is important to address changes in bacterial physiology under stress13.
Environmental signals within hospital settings and the host have been previously shown to play a role in viru-
lence, biofilm formation, DNA-acquisition, and metabolism in A. baumannii11–16. Studies addressing the response 
of A. baumannii to environmental stimuli, such as mucin, light, antibiotics, bile salts, etc., demonstrate that A. 
baumannii behavior is affected11–14. An increase in genes involved in biofilm formation, degradation of pheny-
lacetic acid, metabolic pathways, and genes coding for the type VI secretion system (T6SS), were observed in A. 
baumannii ATCC 19606T ans A. baumannii ATCC 17978 under mucin or blue light treatment11,14. Furthermore, 
growth in the presence of bile salts resulted in an increase in expression of genes associated with acid tolerance, 
quorum sensing, T6SS, and surface motility/biofilm, results that were supported by phenotypic assays analyzing 
biofilm formation and surface associated motility12. Interestingly, transcriptomic analysis of MDR A. baumannii 
under different antibiotic treatments showed that antibiotic treatment was associated with an increase in expres-
sion with genes associated with transposable elements13.
In addition, in-vivo studies where transcriptomic analysis was performed to address the response of A. bau-
mannii during bacteremia showed a decreased expression in 557 protein-coding genes, while 329 showed an 
increased expression17. This analysis also showed that genes associated with the siderophore iron uptake cluster 
were greatly up regulated. In addition, they observed that genes related to metabolism, quorum sensing and bio-
film formation were also affected, showing its ability to adapt to changing environments17.
Other studies, where transposon-directed insertion-sequencing was used, 89 mutants were identified that 
showed a reduced fitness during bacteremia and spleen colonization18.
Recently, Traglia et al. 2016, showed that albumin, the main protein in blood, and Ca2+ significantly enhance 
transformation frequency and increase expression levels of two competence genes (comEA and pilQ) in A. bau-
mannii strains16. The role of human serum albumin (HSA) in the adaptation to host environments and virulence 
was observed in other human pathogens, such as Staphylococcus aureus, group G streptococci, Bordetella pertus-
sis, and Toxoplasma gondii among others19–23. Considering our previous observation, as well as those of others 
studying the dynamics of gene expression of A. baumannii challenged by a variety of stimuli, we conducted a 
transcriptomic analysis of A. baumannii (A118 strain) under HSA treatment to better understand the role of 
this human protein on the survival and persistence of this pathogen15. Surprisingly, we found that 296 genes 
showed statistically significant differences in expression under HSA treatment. Genes involved in motility, bio-
film formation, efflux pumps, metabolism, capsule synthesis, transcriptional regulation, antibiotic resistance and 
pathogenesis were identified. The data obtained serves as the foundation to study key phenotypes related with the 
pathogenesis of this pathogen.
Results and Discussion
Identification of A. baumannii genes altered during exposure to HSA. Considering our previous 
observations on the role of HSA as an inducer of transformation15, we searched for genes that were expressed 
differently under these conditions by using RNA-seq technology.
Our analysis showed that HSA significantly affects the expression of 296 coding genes, of which 111 and 185 
coding genes have a False Discovery Rate (FDR adjusted P-value) of <0.05 and <0.1, respectively and were con-
sidered to search and confirm relevant phenotypes (See Supplementary Fig. S1). Among them, 23 genes exhibited 
an increase in expression (up regulation) while 273 genes exhibited a decrease in expression (down regulation) 
(See Supplementary Fig. S1).
One hundred and eighty-nine of the differentially expressed gene products had annotated biological func-
tions, which allowed us to categorize them in categories based on their location in the cell, their biological func-
tion and their molecular function (See Supplementary Fig. S2).
Change in the expression of genes involved in motility and persistence. Our transcriptomic anal-
ysis revealed four genes (pilQ, yebC, h-ns, exbD) significantly differentially expressed under HSA treatment that 
are involved in cell motility (see Supplementary Table S1). To examine the effect of HSA on surface associated 
motility, motility assays were performed. Our results showed an average 7.28 mm increase in motility diameter 
when cells were grown in the presence of HSA as compared to those grown in the control media (LB) (Fig. 1A).
As previously described, the type IV pilus is crucial in surface motility in A. baumannii24. During this process, 
the type IV pilus extends through a channel in the bacteria outer-membrane and binds to a surface in the environ-
ment. As retraction occurs, the pili remains bound and the bacterial cell is pulled, allowing it to move25,26. pilQ, a 
gene involved in surface motility and DNA acquisition, was expressed differentially under HSA induction. PilQ is 
the outer secretion protein found in type IV pili that allows double-stranded DNA to enter into the periplasm27. 
Previously, Traglia et al. 2016, showed that BSA can enhance transformation rates and induce the expression of 
the competence-related genes comEA and pilQ16. This result and the observations reported in Quinn et al. 2017, 
show that HSA has a singular and significant impact on transformation frequencies15. In addition, the expression 
of pilQ was confirmed to be statistically significant up regulated by qPCR analysis, which revealed a 1.80-fold 
increase in expression under HSA induction (Fig. 1B). After examining additional type IV pilus biogenesis and 
functions genes28–30, we found that 22 genes were also up regulated and only two genes were down regulated 
under HSA induction (Fig. 1C).
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Figure 1. Phenotypic and genetic analysis of surface associated motility genes. (A) Motility assays resulted in 
a significant increase (P-value < 0.05) in the diameter of motility (mm) when grown in the presence of HSA. 
Cells grown with HSA had an average increase in diameter of motility of 7.28 mm. Experiments were performed 
in triplicate, with at least three technical replicates per biological replicate. Statistical analysis (Mann-Whitney 
test) was performed using GraphPad Prism (GraphPad software, San Diego, CA, USA), and a P-value < 0.05 
was considered significant. (B) Quantitative PCR was performed to confirm the differential expression of 
pilQ. Results showed an increase in the expression of pilQ of 1.795-fold (P-value 0.0286). Experiments were 
performed in triplicate, with four technical replicates per biological replicate. Statistical analysis (Mann-
Whitney test) was performed using GraphPad Prism (GraphPad software, San Diego, CA, USA), and a 
P-value < 0.05 was considered significant. (C) A heatmap outlining the differential expression of 30 genes 
associated with motility shows that the majority of motility associated genes are up regulated (green) while 
the three associated transcriptional regulators are down regulated (red). (D) A heatmap outlining the putative 
H-NS regulated genes shows variation in the differential expression of these genes.
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In addition, two transcriptional regulators (yebC and h-ns) that were expressed differently under HSA treat-
ment were identified and may play a role in motility in A. baumannii under HSA induction (see Supplementary 
Table S1). NCBI BLAST and gene ontology analysis identified yebC as a putative transcriptional regulator that 
likely has sequence specific DNA binding activity. In Pseudomonas aeruginosa, the homologous gene product 
(61% identity) has been shown to negatively regulate quorum sensing31,32. Furthermore, it was recently shown 
that in A. baumannii the presence of a quorum quenching signal aidA, which inhibits quorum sensing, leads to a 
decrease in the expression of pilT and adeB12. As pilT is known to be essential for twitching motility, the decrease 
seen under quorum quenching conditions supports the hypothesis that pilT is up regulated under quorum sens-
ing conditions24. Our transcriptomic analysis results identified pilT as up regulated with a log2 fold change of 0.77 
(P-value = 0.46). In line with this, a slight increase in expression of adeB by log2 fold change of 0.4 under HSA 
induction was observed as well (P-value = 0.54). The gene abaI, involved in N-acyl homoserine lactone synthase 
activity, was also up regulated by a log2 fold change of 0.23 (P-value = 0.47) upon HSA exposition. Additionally, 
quorum quenching gene aidA and transcriptional regulator yebC were notably down regulated upon induction 
of HSA with a log2 fold change of −0.09 and −0.87 respectively (P-value > 0.05). Together, these results led us to 
hypothesize that these two genes may be negatively regulating quorum sensing genes in A. baumannii under HSA 
induction. Moreover, the decrease in expression of aidA and yebC could be in line with the increase in surface 
associated motility gene expression that was observed.
The other transcriptional regulator found significantly down regulated under HSA was the global transcrip-
tional repressor h-ns, known to play a role in the expression of virulence traits10. Eijkelkamp et al. 2013, when 
investigating the genomic features of a hypermotile variant of the A. baumannii strain ATCC 17978, observed the 
disruption by an insertion sequences of the h-ns gene. This result led us to hypothesize that the decreased expres-
sion of h-ns (log2 fold change = −2.07) under HSA treatment could also explain in part the increased motility 
observed. H-NS was also observed to play a role in the regulation of gene expression of different virulence traits 
including the gene that codifies for the autotransporter Ata, the putative signal peptide of the Type VI secretion 
system, genes involved in biosynthesis of quorum-sensing signals, and genes of the phenylacetic acid degradation 
pathway10. Considering this data, we searched for those genes in our transcriptional analysis and we found the 
same tendency in the expression of the previous mentioned putative H-NS regulated genes (Fig. 1D).
The gene exbD, shown to be statistically significant and differentially expressed, is neither a pilus associated 
gene nor a transcriptional regulator. This gene caught our attention as it may play a role in Type IV pilus assembly 
and twitching motility33. This gene was identified as a biopolymer transporter by NCBI BLAST and is suspected 
to be a part of the ExbB-ExbD-TonB transport system in A. baumannii. While this system has been shown to 
play an important role in iron-acquisition in A. baumannii, its role in E. coli as flagellar motor proteins and its 
potential role in twitching motility in P. aeruginosa led us to propose that it could have a role in surface associated 
motility34,35. Interestingly, exbD is down regulated (log2 fold change = −1.77) under HSA induction, suggesting 
that further research is necessary to understand the complex relationship between this gene, motility and DNA 
uptake.
Considering that biofilms play a key role in the survival and persistence of A. baumannii on biotic and abiotic 
surfaces, we searched for genes associated with biofilm formation in our transcriptomic analysis results36. We 
identified two genes, fimA and ompA, that were statistically differentially expressed under HSA induction. fimA 
gene was identified by NCBI BLAST as a Type I fimbrial protein and according to its associated gene ontology 
terms; this gene is hypothesized to play a role in cell adhesion and biofilm formation. In addition, ompA is known 
to play a role biofilm formation on plastic and for being essential for A. baumannii attachment to Candida albi-
cans filaments and human alveolar epithelial cells37. Interestingly, these genes showed a log2 fold change of −1.64 
and −2.32 which led us to test the ability of A. baumannii strain A118 to form biofilm in the presence or absence 
of HSA. Our result showed a 1.4-fold decrease (P-value = 0.31) in biofilm formation when cells were grown in 
the presence of HSA (Fig. 2A). Since it is well known that the csu operon is essential for A. baumannii biofilm 
formation, we searched in our transcriptomic analysis results for the level of expression of this operon under HSA 
treatment and found that while csuA and csuC, were down regulated, csuBDE were slightly up regulated (Fig. 2B) 
(see Supplementary Table S2)36,38. We also looked for the two-component regulatory system from A. baumannii 
that regulates biofilm formation, and we found that bfmR and bfmS were down regulated, which can in part 
explain the observed phenotype (Fig. 2B)39.
The ability to produce capsules is known to be an important virulence factor in several bacterial pathogens 
such as Klebsiella pneumoniae, Streptococcus pneumoniae, and A. baumannii40. In A. baumannii, capsule synthesis 
has been linked with the K locus, in which the genes present are responsible for activation of sugar precursors, 
capsule export, modifications of glycans etc.41,42. In a recent report, a subpopulation of A. baumannii cells with 
a thicker capsule and opaque appearance, were linked to an increase in antibiotic and disinfectant resistance as 
well as tolerance to desiccation43. The ability to switch between an opaque and translucent phenotype was linked 
to a master transcriptional regulator, which could cause the change between the virulent and non-virulent colo-
nies, respectively. Possessing such a switch equips A. baumannii with the possibility to modulate its virulence in 
accordance with its environment.
According to our transcriptomic analysis, all 21 K locus genes present in A118 were up regulated under HSA 
induction, including wzc and gpi, which are statistically significantly differentially expressed, and are involved in 
the organization of capsule synthesis and carbohydrate biosynthesis, respectively (Fig. 3A,B and C)42. To explore 
the possibility of switching between opaque and translucent colonies, phase-contrast microscopy was used. A 
difference in capsule synthesis between growth in LB or LB + HSA was not seen and both conditions displayed 
an opaque phenotype (Fig. 3C). Interestingly, Tipton et al. 2015, linked an opaque phenotype to an increase in 
surface motility in the A. baumannii strain AB5075, which is consistent with the increase in motility under HSA 
treatment (Fig. 1A)44. Collectively, our transcriptomic results are in accordance with the phenotypic findings 
leading to the conclusion that A. baumannii can use capsule synthesis as a way to persist in the host.
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Next, we decided to explore A. baumannii persistence during infection. Considering that global transcrip-
tional regulators, such as the previously described yebC and h-ns, have a role in the expression of virulence 
features, plasma survival assays were conducted. The YebC protein family, has been shown to act as negative 
transcriptional regulator of proteolytic genes in both P. aeruginosa and Lactobacillus36,45. In fact, the derepres-
sion of YebC in the Lactobacillus proteolytic system plays a key role in furthering of bacterial growth under 
nutrient depleting conditions45. The function of yebC has yet to be characterized in A. baumannii; however, 
considering the global transcriptional regulators role in expression of virulence features and the association 
of YebC with proteolytic systems, we hypothesized that a protease involved in immune clearance is secreted 
under HSA induction. Furthermore, immune defense against A. baumannii has been shown in murine lung 
models to rely on neutrophil-secreted calprotectin, a zinc chelator, to inhibit growth44. Therefore, we speculated 
the utilization of zinc in the actions of a potentially YebC regulated protease. Thus, plasma survival assays were 
performed in the presence of 25 nM and 25uM zinc, respectively, to quantify the potential delay of immune clear-
ance. Supplementing plasma samples with 25 nM zinc resulted in a 2.01-fold increase in survival at 90 minutes 
(P-value = 0.01) and a 2.10-fold increase in survival at 120 minutes (P-value = 0.14) (Fig. 4A and B). Inactivation 
of heat-labile plasma proteins resulted in an increase of A. baumannii survival at both time points, and addition 
of zinc in heat-inactivated plasma was not statistically significant. Therefore, the statistically significant increase 
in survival rate under zinc supplementation at 90 minutes in plasma (Fig. 4A) signifies the impact zinc availability 
has on A. baumannii survival in the presence of active humoral plasma proteins. A similar trend was observed at 
120 minutes (Fig. 4B); however, the reported values were not statistically significant.
Additionally, concentrating zinc to 25uM culminated in an even higher rate of survivability, with a 2.93-fold 
increase in survival at 90 minutes (P-value = 0.003) and a 2.43-fold increase at 120 minutes (P-value = 0.103) 
(Fig. 4A and B). For both time points, a general trend of increased survival with augmented zinc supplementation 
was observed, indicating a positive correlation between zinc availability and A. baumannii survival in human 
plasma.
In addition, we found a zinc dependent hydrolase encoded by blh_1 that was slightly up regulated (see 
Supplementary Table S2). Bacterial hydrolases that use zinc as a co-factor have been shown to be an impor-
tant part of pathogenesis, encoding different metalloproteases and ß-lactamases that respond in various 
survival-threatening conditions, including: ß-lactam presence, host barriers, neutrophil secretion, cytokine/inter-
leukin signaling, immunoglobulin action, and other immunological responses to pathogen invasion46.
Avoiding immune clearance is an important strategy for survival during bacterial pathogenesis, and human 
plasma is an excellent candidate for characterizing this immune clearance due to the various humoral immune 
proteins present. The main proteins making up 7% of human plasma include HSA, globulins, fibrinogen, and 
other regulatory proteins47. Furthermore, increasing zinc availability in plasma survival assays of A. baumannii, 
Figure 2. Phenotypic and genetic analysis of biofilm formation associated genes. (A) Biofilm assays performed 
with and without HSA show a decrease in biofilm formation (1.4-fold decrease), as represented by OD580/OD600, 
when grown in the presence of HSA. Experiments were performed in triplicate, with at least three technical 
replicates per biological replicate. Statistical analysis (Mann-Whitney test) was performed using GraphPad 
Prism (GraphPad software, San Diego, CA, USA), and a P-value < 0.05 was considered significant. (B) The 
associated heatmap outlines the differential expression of 9 genes associated with biofilm formation, including 
fimA, ompA, the csu operon and its regulator bfmRS.
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results in increased survival, suggesting that a persistence mechanism exists to inhibit host coagulation cascades 
and/or reduce the activity of resident plasma proteins involved in immune clearance by zinc-dependent hydro-
lases. This is further corroborated by the up regulation of zinc transporters znuB and znuC, as well as the down 
regulation of the znu operon transcriptional repressor zur (see Supplementary Table S2). This zinc availabil-
ity strategy may be a persistence mechanism exhibited by A. baumannii as the co-factor could be shuttled to 
zinc-dependent hydrolases that play a role in survival in the host environment. Further studies using in-vivo 
models are necessary to explore the relationship between zinc availability and A. baumannii survival, as well as to 
illuminate which plasma proteins the potential zinc-hydrolase targets.
HSA can have a role in the expression of genes related with resistance to ß-lactams. A. bau-
mannii is known to express a wide range of antimicrobial resistance factors, but in this particular case, multi-
ple ß-lactam resistance mechanisms were specifically differentially expressed in the presence of HSA. Among 
some of the genes related with ß-lactam resistance, the gene that encodes for the outer membrane protein CarO 
was significantly down regulated (log2 fold change = −2.05). It is known that the loss of CarO is related with 
carbapenem-resistance48. Considering this and the fact that the two ß-lactamases (blaADC and blaOXA-51-like) found 
within the A118 genome were up regulated (log2 fold change = 0.67 and 0.36, respectively) (Fig. 5A) under HSA 
induction, susceptibility assays were performed. A non-statistically significant decrease on the halo of inhibition 
was observed for the two carbapenems tested (imipenem, IMP; and meropenem, MEM) under HSA condition 
Figure 3. Phenotypic and genetic analysis of capsule synthesis genes. (A) The capsule synthesis operon as 
predicted for A. baumannii strain A118. (B) A heatmap outlining the differential expression of 21 genes that 
are members of the capsule synthesis operon. (C) Stereoscopic microscopy images showing capsule synthesis in 
A118 cells grown with or without HSA, A118 cells showed no difference in capsule synthesis when under HSA 
treatment. Ab5075 was used as a control.
www.nature.com/scientificreports/
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(Fig. 5B and C). Changes were not observed for ampicillin, cefazolin, ceftazidime and cefepime. A notable 
decrease in the halo of inhibition for IMP was observed and is shown in Fig. 5C. Minimum inhibitory concentra-
tion (MIC) for MEM was also performed and a fold change increase of 0.65 in the MIC was observed (Fig. 5D). 
This increase in resistance addresses the impact of HSA on the fitness of A. baumannii, as intrinsic upregulation of 
ß-lactamases and down regulation of the CarO porin will lead to better survival of the microbe upon introduction 
of carbapenem antibiotics.
Other antibiotics also effective for A. baumannii treatment, such as gentamicin, amikacin, tigecycline, mino-
cycline and polymyxin B, were tested. No changes were observed in the halo of inhibition in the conditions tested.
HSA can influence expression of genes related with metabolism. Transcriptome analysis revealed 
sixty-one genes statistically significant and differentially expressed under HSA treatment involved in metabolism 
and nutrient acquisition (see Supplementary Table S1 and Fig. 6). Of these sixty-one genes, fifty-five were down 
regulated and six were up regulated. Two of these genes (dctA and mdh) have direct links to central metabolism 
which is important for energy production, cell synthesis, and overall growth capabilities.
dctA encodes an aerobic transmembrane C4-dicarboxylate transport protein that plays a role in uptake of 
C4-dicarboxylates for utilization under aerobic growth conditions49. NCBI BLAST identified the gene product as 
a member of the GltP domain and a Na+/H+ dicarboxylate symporter. dctA was statistically significantly differen-
tially down regulated (see Supplementary Table S1 and Fig. 6). Additionally, a second dicarboxylate transporter, 
GI272, was statistically significantly differentially down regulated (log2 fold change of −1.78). To examine the 
effect of HSA on acquisition of C4-dicarboxylates in relation to aerobic growth, nutrient acquisition assays were 
performed on strain A118 of A. baumannii. Under HSA induction, A118 demonstrated no change in growth 
when mediums were supplemented with various C4-dicarboxylate sources (Fig. 7).
In E. coli, aerobic conditions allow external C4-dicarboxylates substrates of DctA like succinate, fumarate, 
L-malate to be fed into the tricarboxylic acid cycle (TCA) and oxidized. In fact, deletion of dctA led to reduction 
in succinate transport and abolition of fumarate transport, whereas phenotypic assays showed that the gene was 
required for aerobic growth on fumarate, L-malate, and succinate50. Reducing the amount of extracellular succi-
nate, fumarate, and L-malate shuttled into A. baumannii due to the presence of HSA may be a potential persis-
tence strategy. Availability of free dicarboxylates during infection may be limited, therefore down regulation of 
the transmembrane transporter can focus microbial energy on other forms of metabolic pathways. Therefore, the 
Figure 4. Phenotypic and genetic analysis of zinc associated genes. (A) Survival assays at 90 minutes performed 
in pooled human plasma (PHP) and heat-inactivated pooled human plasma (HI-PHP) shows that percent 
survival statistically significantly increases with higher concentrations of zinc in PHP. (B) Survival assays 
at 120 minutes show an increase in survival in PHP with the addition of zinc. (C) A heatmap outlining the 
differential expression of 5 genes associated with zinc survival shows four up regulated (green) genes and one 
down regulated genes (red).
www.nature.com/scientificreports/
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Figure 5. Phenotypic and genetic analysis of ß-lactam genes. (A) A heatmap of three ß-lactam associated 
genes shows the down regulation (red) of carO and the up regulation (green) of ampC and blaOXA51-like. (B) 
Disk-diffusion assays were performed and changes in the halo of inhibition were recorded for cefazolin 
(CZ), ampicillin (AMP), ceftazidime (CAZ), cefepime (FEP), imipenem (IMP) and meropenem (MEM). The 
photographs depict the results of (C) an imipenem (IPM) disk diffusion assay and (D) a meropenem (MP) 
E-test assay for A118 cells cultured with and without HSA.
Figure 6. Central carbon metabolism schematic. Genes involved in central carbon metabolism that were 
statistically differentially expressed under HSA treatment. Words or arrows in red represent statistically 
significant genes that were down regulated. Words or arrows in green represent statistically significant genes 
that were up regulated. A heatmap of central carbon metabolism statistically differentially expressed genes is 
also shown.
www.nature.com/scientificreports/
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nutritional acquisition assays conducted (Fig. 7) should not demonstrate reduced growth patterns under HSA 
treatment, as free dicarboxylates were readily available.
A second metabolism associated gene found to be statistically significant down regulation was mdh (log2 
fold change of −1.93) (see Supplementary Table S1), upon HSA induction. NAD-linked malate dehydrogenase 
is an oxidoreductase which catalyzes the conversion of malate into oxaloacetate using NAD as a cofactor and 
plays an essential role in the TCA cycle. In E. coli, MDH is known to be highly regulated to adapt to changing 
conditions such as aerobic and anaerobic cell growth and is also known to be involved in biofilm growth51. To 
phenotypically characterize the down regulation of mdh by HSA, lysozyme derived cell soluble extracts were 
assayed for NAD+-dependent malate dehydrogenase activity by spectrophotometric analysis of NADH forma-
tion. Malate dehydrogenase activity assays induced by HSA demonstrated a 1.47-fold decrease in NADH forma-
tion (P-value < 0.0001) when supplemented with malate (Fig. 8). Moreover, the reduction of biofilm production 
(Fig. 2A) may be linked to the reduction in malate dehydrogenase activity under HSA induction. This is further 
Figure 7. Phenotypic analysis of C4- dicarboxylate acquisition gene. Growth curves of A. baumannii strain 
A118 in M9 liquid minimal medium supplemented with a sole carbon source of succinate, fumarate, or L-malic 
acid. With or without HSA. nutrient acquisition assays showed no difference in A118 growth, measured at an 
optical density of 600 nm, in single dicarboxylate sourced medias.
Figure 8. Phenotypic analysis of malate dehydrogenase activity. Malic enzymatic assays show that soluble 
extracts of A. baumannii strain A118 grown in LB, with or without HSA, have statistically significant reduced 
NADH formation under HSA induction. NADH formation, an indicator of malic dehydrogenase activity, was 
detected by relative fluorescence units (RFU) at an excitation spectrum of 340 nm and an emission spectrum of 
460 nm.
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confirmed by the correlation of high biofilm forming ability of A. baumannii strain 1656-2 with the up regulation 
of malate dehydrogenase52.
Along with malate dehydrogenase (GI12148), four TCA cycle associated enzymes were statistically signif-
icantly differentially expressed under HSA induction: one up regulated and three down regulated. The gene 
encoding the dihydrolipoamide dehydrogenase subunit of 2-oxoglutarate dehydrogenase complex, which cata-
lyzes the reduction of 2-oxoglutarate to succinyl-CoA (Fig. 6), was statistically significantly up regulated (see 
Supplementary Table S1). Additionally, the subsequent genes in the cycle that encode the enzymes responsible for 
the synthesis of succinate from succinyl-CoA (GI539 and GI540), were statistically significantly down regulated. 
The third gene that was also statistically significantly down regulated is the gene GI1791, which encodes for the 
isocitrate lyase. This enzyme is known to compete with the isocitrate dehydrogenase (IDH) for isocitrate usage 
outside the TCA cycle. The differential expression of these four genes suggests that succinyl-CoA production is a 
favored pathway in A. baumannii in the presence of HSA. Moreover, we also observed a statistically significant up 
regulation of nuoF, GI3232, which encodes subunit F of NADH-ubiquinone oxidoreductase (see Supplementary 
Table S1). NADH-ubiquinone oxidoreductase shuttles electrons to quinones in the respiratory chain to create the 
proton gradient along the membrane that is coupled to energy production (Fig. 6). In gram-negative bacterium, 
inhibition of this vital respiratory enzyme, by the action of polymyxins, results in rapid cell death53. The up reg-
ulation of nuoF (GI3232), coupled with the fact that GI2938 was the only NADH producing enzyme suggests a 
survival strategy implemented by A. baumannii under HSA induction to focus TCA flux on succinyl-coA/NADH 
formation.
Succinyl-coA is a precursor molecule for arginine metabolism, phenylalanine metabolism, synthesis and deg-
radation of ketone bodies, and polyketide biosynthesis. Interestingly, h-ns, the global transcriptional regulator 
mentioned above, was linked with polyketide biosynthesis34. As stated before, h-ns was statistically down regu-
lated upon HSA induction; therefore, we propose a potential persistence strategy associated with polyketide bio-
synthesis in A. baumannii under HSA induction. Polyketide biosynthesis enzymes are involved in the production 
of secondary metabolites that precede the synthesis of natural products implicated in A. baumannii’s motility, 
quorum sensing, and biofilm production54. This demonstrates A. baumannii’s pathoadaptability as it favors alter-
native metabolic pathways that prompt phenotypic switches to promote persistence in the human host.
Another gene statistically significant and differentially expressed, and associated with succinyl-coA produc-
tion, that called our attention was paaA. This gene is part of the paa operon involved in aromatics compounds 
degradation to form acetyl- and succinyl-CoA later used in the TCA cycle55. PAA is involved in the phenylacetic 
acid (PA) catabolic pathway, a virulence associated pathway in A. baumannii. Bhuiyan et al. 2016, showed that 
inhibition of the pathway decreases the severity of the infection in a zebrafish model56. In Burkholderia cepacia 
the mutation of paaA and paaE drastically reduce growth on PA and decrease the virulence of this pathogen57.
In A. baumannii, transcriptomic analysis followed by phenotypic confirmation, showed an increase of the 
degradation of PA when A. baumannii grew in the presence of mucin11. In line with our results, Muller et al. 2017, 
showed that blue light inhibited the PA degradation pathway coding genes14.
To confirm the effect of HSA in the PA catabolic pathway, a growth curve for PA as a sole carbon source in 
0.2% PA was performed and a significant decrease (P-value < 0.05) in growth was observed under HSA condition 
(Fig. 9A). In addition, our transcriptomic analysis showed that eight out of the fourteen genes of the paa operon 
are down regulated (Fig. 9B and see Supplementary Table S2). Among the genes that are up regulated, the repres-
sor paaX and paaY were found. The repression of the expression of this operon could decrease A. baumannii 
virulence allowing it to persist more within the host.
Another possibility is that HSA induction favors other pathways associated with succinyl-coA production, 
like polyketide biosynthesis, mentioned above, and arginine metabolism. In fact, the first enzyme involved in 
Figure 9. Phenotypic and genetic analysis of phenylalanine degradation pathway. (A) Growth curves of A. 
baumannii strain A118 in M9 liquid minimal medium supplemented with 0.2% PA as a sole carbon source. 
(B) A heatmap outlining the differential expression of genes involved in the phenylacetic acid (PA) catabolic 
pathway.
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the L-arginine degradation pathway, encoded by astA, was statistically significantly up regulated in the pres-
ence of HSA. astA encodes arginine-N-succinyltransferase, an enzyme that catalyzes the production of CoA 
and N2-succinyl-L-argnine from succinyl-coA and L-arginine. Our transcriptome analysis revealed that three 
of the five genes of the astCADBE operon that act in the L-arginine degradation pathway were up regulated 
(GI2256-GI2260; see Supplementary Tables S1 and S2). In E. coli, the L-arginine degradation pathway (AST) is 
responsible for use of arginine as a sole nitrogen source during exponential growth58 Therefore, up regulation of 
arginine catabolism under HSA reduction may be a metabolic persistence strategy implemented by A. baumannii.
Other genes of interest than can contribute to A. baumannii pathogenesis. Access to metal ions, 
such as zinc and iron, is essential for A. baumannii’s survival, as these ions are necessary for many cellular pro-
cesses to proceed38. Many hosts employ a strategy that involves the depletion of these essential ions to limit the 
expansion and survival of pathogens and in response, A. baumannii has developed a mechanism to more effi-
ciently sequester and take up iron and zinc38.
Fur, the ferric uptake regulator was also down regulated under HSA induction (log2 fold change = −0.58). 
Genes associated with Fur potentially include the acinetobactin genes and tonB-exbB-exbD system38. Of nineteen 
genes identified as being involved in the biosynthesis and transport of acinetobactin in A. baumannii, all of them 
are were up regulated under HSA59 (Fig. 10A and see Supplementary Table S2).
The Type VI secretion system (T6SS) is a complex secretion system found in a number of Gram-negative 
bacteria and has been shown to play a role in the targeting eukaryotic cells and competitor bacterial cells60. As this 
system is an important virulence factor in A. baumannii and contributes substantially to its success as a pathogen, 
we examined the expression of T6SS associated genes in our transcriptomic analysis60. Of the T6SS core proteins 
(tssA-M), our transcriptomic analysis revealed that all the genes were down regulated being tssD statistically 
significant down regulated with a log2 fold change of −2.16 (Fig. 10B and see Supplementary Table S1). Some of 
the tss genes cluster have been characterized in more detail. For example, in A. baumannii, TssB plays an impor-
tant role in bacterium’s competing ability61. According to our result, tssB gene is down regulated in presence of 
HSA, therefore, HSA could decrease the bacterial competitor activity. Moreover, the tssM gene was reported as 
Figure 10. Phenotypic and genetic analysis of additional genes of interest under HSA treatment. (A) A 
heatmap outlining the differential expression of 22 iron associated genes. (B) A heatmap outlining the 
differential expression of 12 type VI secretion system genes. The associated graph depicts the difference in 
survival of bacterial colonies (E. coli MG1655-Rif- prey) with and without HSA. Representative LB-rifampicin 
plates are included and correspond with the graph. (C) A heatmap outlining the differential expression of 13 
RND-type efflux pump genes.
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suppressor of host innate immune response62 and tssD, which is also known as hcp, can be an additional contrib-
uting gene that could be playing a role in persistence63.
Interestingly, the seven vgrG genes were identified, of which six were up regulated and only one (vgrG_4) was 
down regulated (Fig. 10B and see Supplementary Table S2)64. The role of vgrG in A. baumannii was related with 
rate growth, virulence and antimicrobial susceptibility, however, it is not implicated in biofilm formation64. The 
authors observed that ATCC 19606ΔvgrG exhibited reduced resistance to chloramphenicol (>256 to 96 μg/mL) 
comparing with the isogenic strain64. The observed up regulation in presence of HSA could suggest an increase in 
chloramphenicol resistance. In order to assess this, antimicrobial susceptibility testing in presence and absence of 
HSA were performed and we observed only one-fold increase in the MIC of chloramphenicol resistance (5 μg/mL 
to 10 μg/ml with HSA).
Our results are in agreement with previous observation where not all the core genes of the T6SS are equally 
expressed11,65. Bacterial killing assays were performed to study the biological effect of HSA. A118 and A118 under 
HSA treatment were used as predator, and E. coli MG1655-Rif was used as prey11,65. We observed that A118 kills 
E. coli MG1655-Rif under both conditions, and a fold change increase of 240,000 in killing activity was observed 
in the presence of HSA when compared to the LB condition. This results is in agreement with our transcriptomic 
analysis (Fig. 10B).
A. baumannii contains three RND-type efflux pumps that play an important role in its survival in a host 
and resistance to antimicrobials66,67. AdeABC, which is known to increase resistance to aminoglycosides, tet-
racyclines, fluoroquinolones, trimethoprim, chloramphenicol, ß-lactams, and tigecycline, is regulated by the 
two-component system AdeRS66. AdeFGH, which also confers resistance to chloramphenicol, fluoroquinolones, 
trimethoprim, tetracycline and tigecycline as well as clindamycin and sulfonamide, is regulated by the LysR-type 
transcriptional regulator, AdeL66. AdeIJK, which contributes to resistance to ß-lactams, chloramphenicol, tetra-
cyclines, erythromycin, fluoroquinolones, fusidic acid, novobiocin and trimethoprim, is regulated by the TetR 
transcriptional regulator AdeN66.
Our transcriptomic analysis results revealed that adeAB and its regulator, adeRS, were up regulated under 
HSA induction (Fig. 10C and see Supplementary Table S2). Genes adeAB and adeRS have been known to be asso-
ciated with antibiotic resistance, biofilm formation and virulence from previous studies. Studies from Richmond 
et al. 2016, have shown the deletion of these two genes resulted in an increase of antibiotic susceptibly, decreased 
biofilm formation in abiotic and biotic surfaces, and a decrease in virulence within A. baumannii30. Also, tran-
scriptomic analysis of adeFGH revealed that the coding genes of this efflux pump are up regulated (Fig. 10B and 
see Supplementary Table S2). In contrast, the AdeIJK efflux pump genes were down regulated, and the associated 
transcriptional regulator, adeN, was also down regulated (Fig. 10B and see Supplementary Table S2).
Several bacterial species use the T6SS and/or efflux pumps during biofilm formation45,67,68. Mutations in the 
enteroaggregative E. coli Sci-1 T6SS or avian pathogenic E. coli T6SS genes decrease the ability to form biofilms45. 
This is in line with our biofilm results, where a decrease in biofilm formation in presence of HSA was observed. 
The down regulation of tssA-M genes cluster, the adeIJK operon and its adeN regulator in presence of HSA could 
also explain the decrease of biofilm formation. Thus, A. baumannii could be attenuated its virulence in presence 
of an HSA.
In summary, considering the data obtained from the transcriptomic analysis of A. baumannii (strain A118) 
under HSA treatment, different relevant phenotypes associated with the pathoadaptability and pathogenesis of 
this pathogen were studied. We identified how this essential human protein can play a role in the survival and 
persistence of this pathogen. Among the 296 protein-coding genes that showed statistically significant differential 
expression, we focused on genes associated with motility, biofilm formation, antibiotic resistance, virulence, met-
abolic processes, and transcriptional regulation. Phenotypic analysis of these traits under HSA induction revealed 
an increase in surface-associated motility, a decrease in biofilm formation, a slight increase in antibiotic resistance 
against ß-lactam antibiotics, and a decrease in malate dehydrogenase activity.
A. baumannii infections are associated with attributable mortality levels as high as 60% (through 
community-acquired pneumonia) and 43.4% (through bloodstream infections)1–3. This high rate can be 
explained in part by the acquisition and expression of resistance genes, the ability to produce capsule, biofilm, 
and the possibility to activate different metabolic and acquisition pathways69. Here we observed that HSA has 
a noticeable effect on traits that can help A. baumannii adapt to environmental changes, and can contribute to 
pathogenicity. The observed increase in motility, together with the increase rate in survivability, its’ ability to 
switch metabolism, as well as, as increase antibiotic resistance and virulence under HSA induction, can contribute 
to the success of A. baumannii using a multifactorial approach. We acknowledge that our study has limitations. 
The study was performed in vitro in isolation using only one A. baumannii strain. Despite these limitations, both 
the differential genotype and phenotype effects under HSA treatment were conclusive and are relevant in the 
pathogenesis of this species. We consider this to be solid data that can open new venues for future in vivo studies. 
Further studies can help uncover A. baumannii mechanisms of survival and persistence within the host, as well 
as, explain the utilization of albumin in A. baumannii success as a nosocomial pathogen.
Material and Methods
Bacterial Strains. A. baumannii strain A118 was used for RNA and phenotypic analysis. The strain was iso-
lated from the blood sample of a hospitalized patient in Argentina, has had its genome sequenced and has been 
shown to be naturally competent and susceptible to a variety of antibiotics (Ramirez, 2010; Traglia, 2014). Cells 
were initially plated from
80 °C storage on Cystine lactose electrolyte deficient (CLED) agar to obtain fresh cells and later cultured in 
Luria Bertani (LB) broth at 37 °C.
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RNA Extraction. A118 cells were cultured in Luria Bertani broth (LB) with or without 0.2% human serum 
albumin (HSA) and incubated with agitation for 18 h at 37 °C. Overnight cultures were then diluted 1:10 in 
fresh LB broth and incubated with agitation for 7 h at 37 °C. RNA was immediately extracted following the TRI 
REAGENT® Kit (Molecular Research Center, Inc., Cincinnati, Ohio, USA). Briefly, cell pellets were lysed in TRI 
REAGENT® and incubated at 23 °C for 5 m. Chloroform was added and samples were incubated at 23 °C for 
15 m and then centrifuged at 13,200 rotations per minute (rpm) at 4 °C for 15 m to induce phase separation. The 
aqueous layer was transferred to a tube containing isopropanol, incubated at room temperature for 10 m and 
centrifuged at 13,200 rpm at 4 °C for 8 m. The RNA pellet was washed with 70% ethanol and allowed to air dry, 
before being dissolved in RNase-free water. Quantification of RNA was performed using a DeNovix DS-11+ 
Spectrophotometer and qualification was assessed on a 1.2% agarose gel via gel electrophoresis. DNase treatment 
was performed following the manufacturer’s instructions (Thermo Fisher Scientific, Waltham, MA, USA) and 
results were quantified as previously described. Samples were confirmed to have no DNA contamination through 
PCR amplification of the 16S rDNA gene as follows: an initial denaturing stage of 95 °C for 5 m, a three-step 
reaction of 95 °C for 1 m, 54 °C for 30 s and 72 °C for 2 m, repeated 28 times, and a final stage of 72 °C for 5 m. 
PCR products were visualized on a 1% agarose gel and genomic DNA extracted from A118 was used as a positive 
control. Extractions were performed in triplicate and control and experimental were performed in parallel.
RNA Sequencing and Analysis. RNA sequencing was outsourced to Otogenetics (Otogenetics 
Corporation, Atlanta, GA) where they performed ribosomal RNA-depletion using the Ribo-Zero kit (Illumina). 
Construction of the cDNA library was performed with the TruSeq Stranded Total RNA Library Prep kit 
(Illumina) from three independent replicates per sample. Data collected generated an average of 19.5 million 
paired-ends reads per sample with an average of 19.8 and 18.8 total reads for LB (5 replicates) and LB + HAS (3 
replicates), respectively. 3′-end adapter contaminant trimming was done using scythe (available at github.com/
vsbuffalo/scythe). Then, reads were trimmed based on quality using sickle software (available at github.com/
najoshi/sickle), a phred score of 35 was used as threshold. Reads were mapped against the annotated draft genome 
of A118 with the function “align” from the Rsubread package70. Mapped reads (averaged 90%) were counted 
based on the available annotation data using the function “featureCounts”, also from the Rsubread package70. 
Finally, differential expression analysis was carried out with the DESeq. 2 package71. Genes with a FDR adjusted 
P-value of <0.05 and <0.1 were considered as statistically significantly differentially expressed and subject to 
further analysis by Artemis Version 16.0.0, Blast2Go Version 4.1.5, NCBI BLAST and the Kyoto Encyclopedia of 
Genes and Genomes (KEGG). RNA-seq data generated as a result of this work has been deposited to SRA with 
the accession SRP149770.
Real-time RT-qPCR. The cDNA was prepared using the iScript™ Reverse Transcription Supermix for 
RT-qPCR (BioRad, Hercules, CA, USA) per the manufacturer’s instructions and concentrations were meas-
ured with a DeNovix DS-11+ Spectrophotometer. Quantitative PCR was performed using iQ™SYBR® Green 
Supermix (BioRad, Hercules, CA, USA) per the manufacturer’s recommendations. Results were analyzed using 
the 2−ΔΔCt method in which recA acted as the control gene and pilQ the experimental gene. Experiments were 
performed in technical quadruples and biological triplicate and statistical analysis (Mann-Whitney test) was 
performed using GraphPad Prism (GraphPad software, San Diego, CA, USA). A P-value < 0.05 was considered 
significant.
Biofilm Assays with A. baumannii A118 cells. A118 cells were cultured in LB broth with or without 
0.2% HSA and incubated with agitation for 18 h at 37 °C. Overnight cultures were centrifuged at 5,000 rpm at 4 °C 
for 5 and cell pellets were washed twice with 1X PBS and then re-suspended in 1X PBS. Following, the optical 
density at 600 nm (OD600) of each culture was adjusted to 0.9–1.1, vortexed and diluted 1:100 in LB broth before 
being plated in technical triplicate in a 96-well polystyrene micro-titer plate and being incubated at 37 °C for 24 h 
without agitation. The following day, the OD600 (ODG) was measured using a micro-plate reader (SpectraMax 
M3 microplate/ cuvette reader with SoftMax Pro v6 software) to determine the total biomass. Wells were emptied 
with a vacuum pipette, washed three times with 1X phosphate-buffered saline (PBS) and stained with 1% crystal 
violet (CV) for 15 m. Excess CV was removed by washing three more with 1X PBS and the biofilm associated with 
the CV was solubilized in ethanol acetate (80:20) for 30 m. The OD580 (ODB) was measured using a micro-plate 
reader and results were reported as the ratio of biofilm to total biomass (ODB/ODG). Experiments were per-
formed in triplicate, statistical analysis (Mann-Whitney test) was performed using GraphPad Prism (GraphPad 
software, San Diego, CA, USA), and a P-value < 0.05 was considered significant.
Motility Assays. Motility agar plates were made by dissolving 10 g LB broth powder (containing 5 g tryptone, 
2.5 g NaCl, and 2.5 g yeast extract) and 2.5 g agarose in 1 L of de-ionized water to make 0.25% LB agarose plates. 
A118 cells were cultured in LB broth with or without 0.2% HSA and incubated with agitation for 18 h at 37 °C. 
4 μL of the overnight culture was pipetted on to the center of the motility plate and was incubated at 37 °C for 
24 h. The following day, the diameter of growth was measured and was classified as non-motile (<5 mm), inter-
mediately motile (5–20 mm) or highly motile (>20 mm). Experiments were performed in triplicate, with at least 
three technical replicates per biological replicate. Statistical analysis (Mann-Whitney test) was performed using 
GraphPad Prism (GraphPad software, San Diego, CA, USA), and a P-value < 0.05 was considered significant.
Opaque and translucent variants. To distinguish between opaque and translucent colonies the previously 
described protocol was followed44. Briefly, A118 cells with and without HSA were cultured for 18 h and then 
plated on agar plates composed of LB broth supplemented with 0.8% agar for 24 h. Ab5075 was used as control43. 
The colonies were observed using a stereo microscope with oblique lighting from underneath.
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Plasma survival assay. The plasma survival assay was performed in triplicate and prepared in the presence 
or absence of 25 nM ZnCl2 or 25 uM ZnCl2. Three separate conditions were used: LB broth, 90% pooled human 
plasma (in 1 × PBS), and heat-inactivated 90% pooled human plasma. All pooled human plasma samples were 
acquired from a certified vendor that obtains blood samples from FDA-approved facilities (Innovative Research, 
MI USA). Heat inactivation of 90% pooled human plasma was done at 56 °C for 30 minutes. Overnight culture 
was then diluted 106 fold in 1× PBS, then the final dilution was diluted further 1:10 to a final volume of 100uL in 
each condition. Dilutions were plated on LB agar at times 0, 60, 90, 120, and 240 minutes. Percent survival was 
then calculated using control samples against experimental plasma samples at the various end points tested18.
Susceptibility assays. Antibiotic susceptibility assays were performed following with the procedures rec-
ommended by the CLSI with slight modifications as described in Ramirez et al.67. Mueller-Hinton agar plates 
were inoculated with 100 µl of a culture of each tested condition (A118 or A118+ HSA) after OD adjustment. 
Antimicrobial commercial disks (BBL, Cockeysville, MD, USA) containing 30 mg of cefepime (FEP), 30 mg of 
ceftazidime (CAZ), and 10 mg of imipenem (IMP) were used, and the plates were incubated at 37 °C for 18 h. The 
assays were performed in triplicate. Statistical analysis (Mann-Whitney test) was performed using GraphPad 
Prism (GraphPad software, San Diego, CA, USA), and a P-value < 0.05 was considered significant.
Nutrient Acquisition Assay. Cultures were grown in LB broth induced with or without human serum albu-
min overnight in 37 °C with shaking. Growth assays were conducted on 96-well plates in triplicate in Minimal 
Medium M9 supplemented with 1uM MgSO4, 1 mM CaCle and either with 0.45% succinate, 0.27% dibasic fuma-
rate, or 0.22% (−) L-malic acid. These concentrations were selected to ensure the same number of carbon atoms 
were present in each respective medium so the activity of the dicarboxylic acid protein could be effectively ana-
lyzed via reduction in growth rate72. In addition, 0.2% phenylacetic acid was used as a carbon source. Wells con-
taining 294 uL of media and 6 uL of culture were incubated for 18 hours in 37 °C with medium shaking. Growth 
was measured at an OD600 every 20 minutes. Statistical analysis (Mann-Whitney test) was performed followed by 
multiple t-test of various time points of the growth curve.
Malic enzymatic assay. Malate dehydrogenase activity was detected in cell soluble extracts of A118 in 
the presence or absence of HSA. 2 mL aliquots were pelleted and resuspended in 80 µL of resuspension Buffer 
(100 mM HEPES, 1 M MgCl2, pH 7.5). Soluble extracts were extracted via lysis of the cell after 0.8 mg of lysozyme 
was added and samples were incubated at 37 °C for 30 minutes. Samples were then centrifuged for 10 minutes 
at 4 °C at 12,000 rpm and supernatants were aliquoted. 16 µL of supernatant was added to 184 µL of forward 
reaction buffer (100 mM HEPES (pH 7.5), 10 mM NAD+, 100 mM (−) L-malic acid, 1 mM dithiothreitol, and 
10 mM MgCl2) per well73,74. Malic enzyme assays were conducted in triplicate and evaluated in the direction of 
malate oxidation to oxaloacetate by assessing the production of NADH. End point absorbance was analyzed via 
spectrophotometric analysis (SpectraMax M3) at 30 °C with an excitation spectrum of 340 nm and an emission 
spectrum of 460 nm.
Bacterial killing assays. Killing assays were carried using A118 and E. coli MG1655-Rif as predator and 
prey, respectively11,65. A118 or A118+ HSA, and E. coli MG1655 and MG1655-Rif LB cultures, were grown and 
were normalized to an OD600 of 0.5 and performed in duplicates. MG1655/MG1655-Rif mixtures were used as 
negative controls. A118 or A118+ HSA and MG1655-Rif were mixed at a predator-prey 1:1 ratio and 5 μl were 
spotted on a dry LB agar plate. After 4 h, the spot was resuspended in 1 ml PBS and 10 μl serial dilutions plated on 
LB agar plate with rifampicin (100 μg/ml)75. Growth of the prey was recorded after incubation at 37 °C for 36 h.
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